J Am Coll Cardiol. 2020 Nov 17;76(20):2391-2411. doi: 10.1016/j.jacc.2020.08.050. Epub 2020 Oct 21.
Consensus regarding a reasonable strategy to manage cardiac conduction disturbances after transcatheter aortic valve replacement (TAVR) has been elusive. This is due to the absence of adequately powered, randomized controlled trials; the often transient nature of the conduction disturbances; evolving technologies; and the interplay of cardiology subspecialties involved. In the absence of high-quality trials, numerous practice styles have been developed, and prolonged observation, electrophysiological testing, and pre-emptive pacemaker implantation have been described. Although the 2013 European Society of Cardiology guidelines address pacing post-TAVR, they do not provide in-depth discussion of this topic. Furthermore, a summary and proposed strategy for this problem have not been published by cardiovascular societies in the United States, despite an interest in establishing best practices in TAVR, valvular heart disease, and cardiovascular implantable electrical devices. This document reviews existing data and experience regarding the management of conduction disturbances after TAVR and proposes an evidence-based expert consensus decision pathway for their management. Where evidence is lacking or insufficient, the recommendations herein are based on expert opinion.
对于经导管主动脉瓣置换术(TAVR)后心脏传导障碍的合理管理策略,尚未达成共识。这是由于缺乏足够有力的随机对照试验;传导障碍的短暂性;不断发展的技术;以及涉及的心脏病学亚专业的相互作用。在缺乏高质量试验的情况下,已经开发出许多实践方法,并且已经描述了延长观察、电生理测试和预防性起搏器植入。尽管 2013 年欧洲心脏病学会指南涉及 TAVR 后的起搏,但它们并没有深入讨论这个问题。此外,尽管对 TAVR、瓣膜性心脏病和心血管植入式电子设备的最佳实践感兴趣,但美国的心血管学会尚未就这个问题发表总结和提出建议策略。本文回顾了 TAVR 后传导障碍管理的现有数据和经验,并提出了基于证据的专家共识决策途径来管理这些障碍。在缺乏或证据不足的情况下,本文中的建议基于专家意见。